Serum and cerebrospinal fluid Neudesin concentration and Neudesin Quotient as potential circulating biomarkers of a primary brain tumor

BMC Cancer. 2019 Apr 5;19(1):319. doi: 10.1186/s12885-019-5525-4.

Abstract

Background: Despite the previously suggested role of Neudesin in tumorigenesis and its potential as a novel target for the treatment of cancers, its prognostic value has never been examined. Thus, the aim of the study was to evaluate Neudesin concentrations in primary brain tumor patients and make a comparison with non-tumoral individuals.

Methods: Cerebrospinal fluid (CSF) and serum Neudesin concentration was evaluated by means of the ELISA method.

Results: The total group of brain tumor patients had statistically lower serum Neudesin concentrations compared to the non-tumoral group (P = 0.037). The meningeal tumor subgroup also had statistically lower serum Neudesin concentrations compared to the non-tumoral group (P = 0.012). The Astrocytic brain tumor subgroup had significantly higher CSF Neudesin concentrations compared to the non-tumoral group (P = 0.046). Neudesin Quotient (CSF concentration divided by serum concentration) in the astrocytic brain tumor subgroup was statistically higher compared to the non-tumoral group (P = 0.023). Males had statistically lower concentrations of the serum Neudesin compared to females (P = 0.047). Univariate linear regression analysis revealed that for women the serum Neudesin concentration was 1.53 times higher than for men. In the model of multivariate linear regression analysis, predictor variables influencing serum Neudesin concentrations included CSF Neudesin concentration and the Neudesin Quotient, if other model parameters are fixed. The developed model explains 82% of the variance in serum Neudesin concentration. Both linear regression models, univariate and multivariate, pointed to fewer factors with a potential to influence the Neudesin Quotient compared to serum Neudesin concentration.

Conclusions: In astrocytic brain tumor patients Neudesin concentrations within the cerebrospinal fluid are higher compared with non-tumoral individuals. Serum Neudesin concentration strongly correlates with its CSF level. In primary brain tumor patients serum Neudesin concentration is clearly gender-dependent. Linear regression models pointed to fewer factors that may influence the Neudesin Quotient value, which suggests it is a better biomarker of astrocytic brain tumors than serum and CSF Neudesin concentrations alone.

Keywords: Biomarker; Cerebrospinal fluid; Neudesin; Primary brain tumor.

Publication types

  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Astrocytoma / blood
  • Astrocytoma / cerebrospinal fluid
  • Astrocytoma / diagnosis*
  • Biomarkers, Tumor / analysis*
  • Brain Neoplasms / blood
  • Brain Neoplasms / cerebrospinal fluid
  • Brain Neoplasms / diagnosis*
  • Case-Control Studies
  • Female
  • Humans
  • Intercellular Signaling Peptides and Proteins / analysis*
  • Linear Models
  • Male
  • Middle Aged
  • Models, Biological*
  • Nerve Tissue Proteins / analysis*
  • Predictive Value of Tests
  • Sex Factors

Substances

  • Biomarkers, Tumor
  • Intercellular Signaling Peptides and Proteins
  • NENF protein, human
  • Nerve Tissue Proteins